Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A McKinlay

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Biological Chemistry|March 12, 2011
Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerizationRebecca Feltham, Bodhi Bettjeman, Rhesa Budhidarmo, et al.
BMJ Global Health|September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in SwedenElizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
Journal of Virology|December 5, 2022
Biographical Feature: Marc S. Collett (23 May 1951-11 June 2022): the Battle against Viral Disease Has Lost a Valiant Warrior, and the World Has Lost a Splendid Human BeingKimberly F Glassman, Joan S Brugge, Anthony F Purchio, et al.
Molecular Cancer Therapeutics|February 25, 2014
Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft modelsChristopher A Benetatos, Yasuhiro Mitsuuchi, Jennifer M Burns, et al.
Frontiers in Immunology|September 28, 2017
Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio EradicationAsghar Aghamohammadi, Hassan Abolhassani, Necil Kutukculer, et al.
Journal of Medicinal Chemistry|April 2, 2014
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignanciesStephen M Condon, Yasuhiro Mitsuuchi, Yijun Deng, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Biological Chemistry|March 12, 2011
Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerizationRebecca Feltham, Bodhi Bettjeman, Rhesa Budhidarmo, et al.
BMJ Global Health|September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in SwedenElizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
Journal of Virology|December 5, 2022
Biographical Feature: Marc S. Collett (23 May 1951-11 June 2022): the Battle against Viral Disease Has Lost a Valiant Warrior, and the World Has Lost a Splendid Human BeingKimberly F Glassman, Joan S Brugge, Anthony F Purchio, et al.
Molecular Cancer Therapeutics|February 25, 2014
Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft modelsChristopher A Benetatos, Yasuhiro Mitsuuchi, Jennifer M Burns, et al.
Frontiers in Immunology|September 28, 2017
Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio EradicationAsghar Aghamohammadi, Hassan Abolhassani, Necil Kutukculer, et al.
Journal of Medicinal Chemistry|April 2, 2014
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignanciesStephen M Condon, Yasuhiro Mitsuuchi, Yijun Deng, et al.
Pageof 2